ASCO Post: Momelotinib for Symptomatic and Anemic Patients With Myelofibrosis Posted on June 13, 2022 at 10:28 am.Shared by contributor Dr. Ruben Mesa, Mays Cancer Center, is quoted in this article. Read More Share This Article!
